DongKook Pharmaceutical Co. Ltd (KQ:086450) — Stock Price

₩20100.00 KRW
▲ 4.15% today

DongKook Pharmaceutical Co. Ltd (KQ:086450) is currently trading at ₩20100.00 KRW, up 4.15% today. Over the past 52 weeks, shares have ranged between ₩16420.00 and ₩29900.00. This page tracks DongKook Pharmaceutical Co. Ltd's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see DongKook Pharmaceutical Co. Ltd stock valuation.

DongKook Pharmaceutical Co. Ltd (086450) Stock Price Chart — Daily History & Trading Volume

The chart below tracks DongKook Pharmaceutical Co. Ltd's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

DongKook Pharmaceutical Co. Ltd Income Statement — Revenue, Profit & Earnings by Year

DongKook Pharmaceutical Co. Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue ₩926.88 Billion ₩812.17 Billion ₩730.99 Billion ₩661.65 Billion ₩594.19 Billion
Cost of Revenue ₩425.29 Billion ₩364.27 Billion ₩320.21 Billion ₩281.82 Billion ₩243.93 Billion
Gross Profit ₩501.60 Billion ₩447.90 Billion ₩410.78 Billion ₩379.83 Billion ₩350.26 Billion
Research & Development ₩32.82 Billion ₩30.33 Billion ₩25.46 Billion ₩23.10 Billion ₩24.69 Billion
SG&A ₩273.53 Billion ₩329.66 Billion ₩312.71 Billion ₩279.44 Billion ₩258.08 Billion
Total Operating Expenses ₩830.33 Billion ₩731.75 Billion ₩664.12 Billion ₩588.99 Billion ₩530.97 Billion
Operating Income ₩96.55 Billion ₩80.42 Billion ₩66.87 Billion ₩72.65 Billion ₩63.22 Billion
EBITDA — — — — —
EBIT — — — — ₩63.22 Billion
Interest Expense ₩2.08 Billion ₩4.50 Billion ₩5.87 Billion ₩4.32 Billion ₩2.88 Billion
Income Before Tax ₩92.59 Billion ₩84.74 Billion ₩60.84 Billion ₩68.63 Billion ₩69.75 Billion
Income Tax Expense — — — — ₩16.84 Billion
Net Income ₩66.02 Billion ₩61.22 Billion ₩47.18 Billion ₩52.90 Billion ₩50.35 Billion

DongKook Pharmaceutical Co. Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes DongKook Pharmaceutical Co. Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets ₩1.06 Trillion ₩953.16 Billion ₩839.54 Billion ₩768.33 Billion ₩750.08 Billion
Total Current Assets ₩565.40 Billion ₩470.01 Billion ₩419.20 Billion ₩385.32 Billion ₩420.23 Billion
Cash & Equivalents — ₩50.27 Billion ₩60.55 Billion ₩73.69 Billion ₩85.44 Billion
Short-term Investments ₩70.92 Billion ₩40.58 Billion ₩33.61 Billion ₩30.26 Billion ₩83.49 Billion
Net Receivables ₩222.16 Billion ₩180.59 Billion ₩161.11 Billion ₩134.07 Billion ₩123.95 Billion
Inventory ₩175.25 Billion ₩159.58 Billion ₩138.34 Billion ₩120.15 Billion ₩102.59 Billion
Property, Plant & Equipment — ₩299.46 Billion ₩272.70 Billion ₩263.36 Billion ₩234.94 Billion
Goodwill ₩12.17 Billion ₩12.17 Billion — — —
Total Liabilities ₩299.16 Billion ₩274.19 Billion ₩263.36 Billion ₩266.39 Billion ₩295.51 Billion
Total Current Liabilities ₩267.41 Billion ₩232.69 Billion ₩231.15 Billion ₩198.54 Billion ₩220.27 Billion
Long-term Debt ₩15.69 Billion ₩22.90 Billion ₩18.75 Billion ₩25.00 Billion ₩10.00 Billion
Net Debt ₩11.60 Billion ₩21.60 Billion ₩12.15 Billion — ₩6.75 Billion
Total Stockholder Equity ₩663.74 Billion ₩603.48 Billion ₩544.69 Billion ₩501.94 Billion ₩454.57 Billion
Retained Earnings ₩612.97 Billion ₩558.21 Billion ₩507.32 Billion ₩467.18 Billion ₩419.76 Billion

DongKook Pharmaceutical Co. Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how DongKook Pharmaceutical Co. Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow ₩68.76 Billion ₩76.09 Billion ₩41.79 Billion ₩40.91 Billion ₩44.65 Billion
Capital Expenditures ₩46.00 Billion ₩30.80 Billion ₩39.35 Billion ₩51.23 Billion ₩51.01 Billion
Free Cash Flow ₩22.76 Billion ₩45.29 Billion ₩2.44 Billion ₩-10.32 Billion ₩-6.77 Billion
Investing Cash Flow — ₩-64.86 Billion ₩-52.39 Billion ₩-12.41 Billion ₩-43.53 Billion
Financing Cash Flow — ₩-22.30 Billion ₩-2.30 Billion ₩-39.79 Billion ₩29.73 Billion
Dividends Paid ₩9.24 Billion ₩8.31 Billion ₩8.05 Billion ₩8.05 Billion ₩8.05 Billion
Stock-Based Compensation ₩-115.89 Million ₩-39.20 Million ₩-162.46 Million ₩-297.31 Million ₩-24.01 Million
Depreciation ₩31.71 Billion ₩27.50 Billion ₩21.10 Billion ₩19.08 Billion ₩17.36 Billion
Change in Cash ₩5.91 Billion ₩-10.28 Billion ₩-13.14 Billion ₩-11.75 Billion ₩30.91 Billion

DongKook Pharmaceutical Co. Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track DongKook Pharmaceutical Co. Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 31, 2026 553.06 — —
Mar 11, 2026 309.95 — —
Nov 12, 2025 445.96 — —
Aug 12, 2025 352.40 — —
May 14, 2025 368.51 — —
Mar 12, 2025 192.89 — —
Nov 12, 2024 428.95 — —
Aug 14, 2024 304.21 — —